Serum inhibin A, inhibin B, and pro-alphaC levels are altered after surgically or pharmacologically induced menopause

Fertil Steril. 2002 Apr;77(4):745-9. doi: 10.1016/s0015-0282(01)03234-4.

Abstract

Objective: To evaluate the course of changes in serum inhibin A, inhibin B, and pro-alphaC levels in women with surgically or pharmacologically induced menopause.

Design: Longitudinal study.

Setting: Academic Health Center of Siena, Siena, Italy.

Patient(s): Four groups of women were studied: [1] surgical menopause including bilateral oophorectomy (n = 15), [2] amenorrhea induced by GnRH-analogue for treatment of endometriosis (n = 13), [3] amenorrhea induced by antineoplastic chemotherapy before (n = 15) and after chemotherapy (n = 13), and [4] control physiological menopause (n = 67).

Intervention(s): Collection of blood specimens.

Main outcome measure(s): Serum inhibin A, inhibin B, and pro-alphaC concentrations were measured by using specific two-site ELISAs.

Result(s): Following oophorectomy, serum inhibin A, inhibin B, and pro-alphaC levels were decreased on the first postoperative day; on the fifth postoperative day they were still significantly reduced. Women with amenorrhea induced by GnRH-analogue treatment exhibited serum inhibin A and pro-alphaC levels that were significantly higher than those observed in physiological menopause. Patients undergoing antineoplastic chemotherapy had higher serum inhibin A levels than those in physiological menopause, whereas inhibin B and pro-alphaC levels did not differ. During the course of chemotherapy, median serum inhibin A concentrations were similar to those of patients evaluated after the suspension of treatment. In postmenopause, inhibin A, and inhibin B levels were low, whereas levels of pro-alphaC were still detectable.

Conclusion(s): Circulating levels of inhibin A, inhibin B, and pro-alphaC are reduced after oophorectomy. Women with amenorrhea induced by GnRH-analogue treatment or by antineoplastic chemotherapy still produce inhibin A and pro-alphaC. This probably reflects a residual ovarian function and hormone synthesis. Therefore, the ovary may be a source of pro-alphaC after menopause; significant amounts of pro-alphaC are present in circulation after natural menopause, but not after oophorectomy.

MeSH terms

  • Amenorrhea / chemically induced*
  • Antineoplastic Agents / adverse effects
  • Endometriosis / drug therapy
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gonadotropin-Releasing Hormone / analogs & derivatives
  • Humans
  • Inhibins / blood*
  • Kinetics
  • Longitudinal Studies
  • Menopause / blood*
  • Middle Aged
  • Ovariectomy*
  • Postmenopause / blood
  • Postoperative Period
  • Protein Precursors / blood*

Substances

  • Antineoplastic Agents
  • Protein Precursors
  • inhibin A
  • inhibin B
  • inhibin-alpha subunit precursor
  • Gonadotropin-Releasing Hormone
  • Inhibins